Does AMISULPRIDE Cause Hyperleukocytosis? 14 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Hyperleukocytosis have been filed in association with AMISULPRIDE (Barhemsys). This represents 0.4% of all adverse event reports for AMISULPRIDE.
14
Reports of Hyperleukocytosis with AMISULPRIDE
0.4%
of all AMISULPRIDE reports
9
Deaths
4
Hospitalizations
How Dangerous Is Hyperleukocytosis From AMISULPRIDE?
Of the 14 reports, 9 (64.3%) resulted in death, 4 (28.6%) required hospitalization.
Is Hyperleukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMISULPRIDE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does AMISULPRIDE Cause?
Drug ineffective (665)
Weight increased (346)
Toxicity to various agents (305)
Suicide attempt (261)
Akathisia (252)
Extrapyramidal disorder (226)
Drug abuse (219)
Leukopenia (218)
Therapeutic product effect incomplete (200)
Off label use (191)
What Other Drugs Cause Hyperleukocytosis?
CYCLOPHOSPHAMIDE (55)
PREDNISONE (54)
TRETINOIN (52)
ARSENIC TRIOXIDE (49)
RITUXIMAB (49)
ACETAMINOPHEN (44)
VINCRISTINE (44)
DEXAMETHASONE (42)
PANTOPRAZOLE (38)
AMOXICILLIN (36)
Which AMISULPRIDE Alternatives Have Lower Hyperleukocytosis Risk?
AMISULPRIDE vs AMITRIPTYLINE
AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE
AMISULPRIDE vs AMIVANTAMAB
AMISULPRIDE vs AMIVANTAMAB-VMJW
AMISULPRIDE vs AMLODIPINE